Objective To discuss the clinical value of thyroid malignancies therapeutic greenway. Methods From Jan. 2016 to Sep.2016 of West China Hospital, 509 patients whose TIRADs classifications were higher than 3B were included. Bethesda system was usded for reporting thyroid Cytopathology (TBSRTC) for cytologic diagnosis Results 509 greenway patients underwent specific thyroid ultrasound examination, 501 patients (501/509, 98.4%) underwent FNAB and 8(8/509, 1.6%) were followed up. The average wait FNAB time was 3 days of greenway patients. However non-greenway patients needed wait 35 days on average. The TBSRTC results were I type(11 cases,21%;81 cases,159%),Ⅱtype（25 cases, 5.0%;96 cases, 189%），Ⅲ type（58 cases， 11%;84 cases, 16.6%），Ⅳ type（8 cases，1.6%;19 cases, 37%），Ⅴ type（39 cases, 7.7%;45 cases, 8.9%）和Ⅵ type（360 cases, 71%;182 cases, 35.7%） of greenway and non-greenway patients respectively. Difference of invalid rate, non diagnostic rate, benign and malignant rate between the two groups was significant（P＜0.01）. Conclusion Greenway for patients with thyroid carcinomas can not only reduce waiting time, but also decrease invalid rate, non diagnostic rate, and benign rate of aspiration biopsy.